Skip to main content
Top
Published in: Journal of General Internal Medicine 12/2015

01-12-2015 | Editorial

Medical Debates and Medical Reversal

Authors: Adam S. Cifu, MD, Vinay K. Prasad, MD, MPH

Published in: Journal of General Internal Medicine | Issue 12/2015

Login to get access

Excerpt

Medical reversal occurs when an accepted practice—a diagnostic test, medication, or procedure—is overturned. The practice is not replaced by something better, but shown to be inferior to a preexisting, less intensive, or less invasive one. Sometimes the practice that is overturned is shown to be inferior to no intervention. Every physician is aware of emblematic cases of reversal, such as the use of hormone therapy in post-menopausal women. Medical reversal is common; well over 100 studies have been published in major medical journals over the last 10 years that provide strong evidence that an accepted medical practice was ineffective or harmful.1,2 The debates that follow these publications—whether the reversal concerns a screening test, surgical procedure, medical therapy, or systems intervention—are among the most contentious in medicine. These arguments are important ones; they ultimately decide how we, as a profession, progress in our effort to provide high-value care, and they articulate how we view the standards of evidence upon which we base our practice. The debates that follow reversals adhere to a predictable script, pitting minimalists against maximalists. These debates also place the practicing physician, who must decide what to actually recommend to patients, in a difficult position. …
Literature
1.
go back to reference Prasad V, Vandross A, Toomey C, et al. A decade of reversal: an analysis of 146 contradicted medical practices. Mayo Clin Proc. 2013;88:790–8.CrossRefPubMed Prasad V, Vandross A, Toomey C, et al. A decade of reversal: an analysis of 146 contradicted medical practices. Mayo Clin Proc. 2013;88:790–8.CrossRefPubMed
2.
go back to reference Wang MM, Gamble G, Grey A. Responses of specialist societies to evidence for reversal of practice. JAMA Intern Med. 2015. Wang MM, Gamble G, Grey A. Responses of specialist societies to evidence for reversal of practice. JAMA Intern Med. 2015.
3.
4.
go back to reference Biller-Andorno N, Juni P. Abolishing mammography screening programs? A view from the Swiss Medical Board. N Engl J Med. 2014;370:1965–7.CrossRefPubMed Biller-Andorno N, Juni P. Abolishing mammography screening programs? A view from the Swiss Medical Board. N Engl J Med. 2014;370:1965–7.CrossRefPubMed
5.
go back to reference Bleyer A, Welch HG. Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence. N Engl J Med. 2012;367:1998–2005.CrossRefPubMed Bleyer A, Welch HG. Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence. N Engl J Med. 2012;367:1998–2005.CrossRefPubMed
6.
go back to reference Miller AB, Wall C, Baines CJ, et al. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ. 2014;348:g366.PubMedCentralCrossRefPubMed Miller AB, Wall C, Baines CJ, et al. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. BMJ. 2014;348:g366.PubMedCentralCrossRefPubMed
Metadata
Title
Medical Debates and Medical Reversal
Authors
Adam S. Cifu, MD
Vinay K. Prasad, MD, MPH
Publication date
01-12-2015
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 12/2015
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-015-3481-5

Other articles of this Issue 12/2015

Journal of General Internal Medicine 12/2015 Go to the issue

Clinical Practice: Clinical Images

Scalloping of the Liver

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine